Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

luigi_costa_credit_nordic_nanovector_headshot

Nordic Nanovector CEO steps down as company delays R&D timelines

April 5, 2018 Medical Communications, Research and Development, Sales and Marketing Luigi Costa, Nordic Nanovector, pharma

Norwegian biopharmaceutical firm Nordic Nanovector has revealed that its Chief Executive Officer Luigi Costa is set to step down from …
News
cystic_fibrosis_insider_interview

Transforming cystic fibrosis treatment

April 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

Fred van Goor, Principle Research Fellow at Vertex Pharmaceuticals, discusses his history of work in cystic fibrosis and how the …
Feature
roche

Roche snaps up Inception neuroscience program

April 5, 2018 Sales and Marketing Pipeline Therapeutics, Roche, biotech, drugs, pharma, pharmaceutical

Back in 2014, Roche entered into strategic collaboration with Inception Sciences to look into the regenerative medicines space for multiple …
News

Boehringer teams up with OSE in €1.1 billion cancer drug partnership

April 5, 2018 Sales and Marketing Boehringer, Cancer, OSE Immunotherapeutics, partnership, pharma

Boehringer Ingelheim and biotech firm OSE Immunotherapeutics have announced that they have entered an exclusive collaboration and license agreement to …
News
lilly2_web

Lilly and Sigilon team up in $473m+ deal to ‘cure’ diabetes

April 5, 2018 Sales and Marketing Eli Lilly, Sigilon Therapeutics, biotech, drugs, pharma, pharmaceutical

Eli Lilly and Sigilon Therapeutics have announced a partnership that looks to break new ground in the management of type …
News

NICE rejects Dupixent for atopic dermatitis on cost grounds, Sanofi responds

April 4, 2018 Research and Development, Sales and Marketing Dupixent, NICE, Sanofi, atopic dermatitis, eczema, pharma

UK drug watchdog NCIE has issued draft guidance rejecting the routine use of Sanofi’s Dupixent (dupilumab) for the treatment of …
News
pfizer_chrome_plate

Pfizer running out of options for consumer business

April 4, 2018 Research and Development, Sales and Marketing P&G, Pfizer, Procter & Gamble, biotech, drugs, pharma, pharmaceutical

A surprise new name was thrown into the ring to take on Pfizer’s healthcare unit but speculation suggests that valuation …
News
shaking-hands-3091908_960_720

Ex-Kite execs form a CAR T rival

April 4, 2018 Research and Development, Sales and Marketing Allogene, Pfizer, biotech, drugs, pharma, pharmaceutical

After working to bring through Kite Pharma from the pre-clinical development stage to its final $12 billion acquisition by Gilead, …
News

Patient experience: Living with ovarian cancer

April 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Ingrid Copperman, feature, ovarian cancer, patient experience, pharma

Ingrid Copperman recounts the many ways she has dealt with her diagnosis, as well as how the power of social …
Feature

One centre for cancer diagnoses trialled

April 3, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical

NHS England is trialling centres that should be able to provide rapid answers as to whether a patient has cancer …
News
fda2outsideweb

Alkermes sent reeling as FDA refuses review of depression treatment

April 3, 2018 Manufacturing and Production, Research and Development, Sales and Marketing Alkermes, FDA, depression, major depressive disorder, pharma

Alkermes shares were knocked down to their lowest level since October 2016 after it was revealed that the FDA had …
News

Rumours Allergan is looking to offload $5bn women’s health unit

April 3, 2018 Manufacturing and Production, Sales and Marketing Allergan, Restasis, biotech, drugs, pharma, pharmaceutical

According to a piece by Bloomberg, Allergan is looking at options to divest its women’s health unit in a move …
News
medimmune_building_cambridge

AZ’s MedImmune signs $200m immuno-oncology partnership with Compugen

April 3, 2018 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, MedImmune, compugen, immunotherapy, oncology, pharma

AstraZeneca’s biologic R&D unit MedImmune is set to enter a partnership with Israeli drug firm Compugen to develop bi-specific and …
News
celgene_1_02

Celgene’s COO heads to the exit

April 3, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing Celgene, Mark Alles, Scott Smith, biotech, drugs, pharma, pharmaceutical

Celgene has had a rough six months, its share price since the beginning of October has dropped from $146 to …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 29, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, Cancer, GSK, Hemlibra, MSD, Roche, Sun Pharma, Takeda, brexit, pharma, tecentriq, top ten

As we approach the Easter weekend, we at Pharmafocus hope all of our readers have a great long weekend, if …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025